Neurodegenerative lysosomal storage disease in European Burmese cats with hexosaminidase β-subunit deficiency

Molecular Genetics and Metabolism

Volumn 97, Issue 1, 2009, Pages 53-59

  Bradbury, Allison M ^a   Morrison, Nancy E ^a   Hwang, Misako ^a   Cox, Nancy R ^a   Baker, Henry J ^a   Martin, Douglas R ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Feline; Gangliosidosis; Hexosaminidase; Lysosomal storage disease; Models, animal; RNA splicing

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; COMPLEMENTARY DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASE PAIRING; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXON; EXPERIMENTAL CAT; FEMALE; GENE DELETION; GENE SEQUENCE; GM2 GANGLIOSIDOSIS; HISTOPATHOLOGY; INTRON; LYSOSOME STORAGE DISEASE; MALE; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SPLICING; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BASE SEQUENCE; BETA-HEXOSAMINIDASE BETA CHAIN; BLOTTING, WESTERN; CAT DISEASES; CATS; CEREBRAL CORTEX; CHROMATOGRAPHY, THIN LAYER; DNA MUTATIONAL ANALYSIS; EUROPE; GANGLIOSIDOSES, GM2; LIPIDS; LYSOSOMAL STORAGE DISEASES; MOLECULAR SEQUENCE DATA; MYANMAR; NERVE DEGENERATION;

ANIMALIA; FELIDAE;

EID: 63649119659     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.01.003     Document Type: Article

References (43)

1. Cork L.C., Munnell J.F., Lorenz M.D., Murphy J.V., Baker H.J., and Rattazzi M.C. GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. Science 196 (1977) 1014-1017
2. Hasegawa D., Yamato O., Kobayashi M., Fujita M., Nakamura S., Takahashi K., Satoh H., Shoda T., Hayashi D., Yamasaki M., Maede Y., Arai T., and Orima H. Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat. J. Fel. Med. Surg. 9 (2007) 232-237
3. Neuwelt E.A., Johnson W.G., Blank N.K., Pagel M.A., Maslen-McClure C., McClure M.J., and Wu P.M. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J. Clin. Invest. 76 (1985) 482-490
4. Pierce K.R., Kosanke S.D., Bay W.W., and Bridges C.H. Animal model of human disease: GM2 gangliosidosis. Am. J. Pathol. 83 (1976) 419-422
5. Cummings J.F., Wood P.A., Walkley S.U., de Lahunta A., and DeForest M.E. GM2 gangliosidosis in a Japanese spaniel. Acta Neuropathol. 67 (1985) 247-253
6. Eto Y., Autilio-Gambetti L., and McGrath J.T. Canine GM2-gangliosidosis: chemical and enzymatic features. Adv. Exp. Med. Biol. 174 (1984) 431-440
7. Sango K., Yamanaka S., Hoffmann A., Okuda Y., Grinberg A., Westphal H., McDonald M.P., Crawley J.N., Sandhoff K., and Suzuki K. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11 (1995) 170-176
8. Phaneuf D., Wakamatsu N., Huang J.Q., Borowski A., Peterson A.C., Fortunato S.R., Ritter G., Igdoura S.A., Morales C.R., Benoit G., Akerman B.R., Leclerc D., Hanai N., Marth J.D., Trasler J.M., and Gravel R.A. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 5 (1996) 1-14
9. Martin D.R., Cox N.R., Morrison N.E., Kennamer D.M., Peck S.L., Dodson A.N., Gentry A.S., Griffin B., Rolsma M.D., and Baker H.J. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathol. 110 (2005) 443-450
10. Martin D.R., Krum B.K., Varadarajan G.S., Hathcock T.L., Smith B.F., and Baker H.J. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant 0. Exp. Neurol. 187 (2004) 30-37
11. Muldoon L.L., Neuwelt E.A., Pagel M.A., and Weiss D.L. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am. J. Pathol. 144 (1994) 1109-1118
12. Kanae Y., Endoh D., Yamato O., Hayashi D., Matsunaga S., Ogawa H., Maede Y., and Hayashi M. Nonsense mutation of feline beta-hexosaminidase beta-subunit (HEXB) gene causing Sandhoff disease in a family of Japanese domestic cats. Res. Vet. Sci. 82 (2007) 54-60
13. Proia R.L. Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes. Proc. Natl. Acad. Sci. USA 85 (1988) 1883-1887
14. Triggs-Raine B.L., Benoit G., Salo T.J., Trasler J.M., and Gravel R.A. Characterization of the murine beta-hexosaminidase (HEXB) gene. Biochim. Biophys. Acta 1227 (1994) 79-86
15. Yamanaka S., Johnson O.N., Norflus F., Boles D.J., and Proia R.L. Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb. Genomics 21 (1994) 588-596
16. Martin D.R., Rigat B.A., Foureman P., Varadarajan G.S., Hwang M., Krum B.K., Smith B.F., Callahan J.W., Mahuran D.J., and Baker H.J. Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis. Mol. Genet. Metab. 94 (2008) 212-221
17. Yamato O., Matsunaga S., Takata K., Uetsuka K., Satoh H., Shoda T., Baba Y., Yasoshima A., Kato K., Takahashi K., Yamasaki M., Nakayama H., Doi K., Maede Y., and Ogawa H. GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats. Vet. Rec. 155 (2004) 739-744
18. Baker Jr. H.J., Lindsey J.R., McKhann G.M., and Farrell D.F. Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency. Science 174 (1971) 838-839
19. Fujimaru M., Tanaka A., Choeh K., Wakamatsu N., Sakuraba H., and Isshiki G. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3′-splice site selection and cause Sandhoff disease. Hum. Genet. 103 (1998) 462-469
20. Nakano T., and Suzuki K. Genetic cause of a juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta chain gene transcript due to a point mutation within intron 12. J. Biol. Chem. 264 (1989) 5155-5158
21. Wakamatsu N., Kobayashi H., Miyatake T., and Tsuji S. A novel exon mutation in the human beta-hexosaminidase beta-subunit gene affects 3′ splice site selection. J. Biol. Chem. 267 (1992) 2406-2413
22. Yoshizawa T., Kohno Y., Nissato S., and Shoji S. Compound heterozygosity with two novel mutations in the HEXB gene produces adult Sandhoff disease presenting as a motor neuron disease phenotype. J. Neurol. Sci. 195 (2002) 129-138
23. McInnes B., Potier M., Wakamatsu N., Melancon S.B., Klavins M.H., Tsuji S., and Mahuran D.J. An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds. J. Clin. Invest. 90 (1992) 306-314
24. House A.E., and Lynch K.W. Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283 (2008) 1217-1221
25. Wang Z., and Burge C.B. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14 (2008) 802-813
26. Fan J.Q., Ishii S., Asano N., and Suzuki Y. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5 (1999) 112-115
27. Ishii S., Chang H.H., Kawasaki K., Yasuda K., Wu H.L., Garman S.C., and Fan J.Q. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem. J. 406 (2007) 285-295
28. Ron I., Horowitz M., Department of Cell R., and Immunology T.A.U.R.A.I. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum. Mol. Genet. 14 (2005) 2387-2398
29. Kim S.J., Zhang Z., Hitomi E., Lee Y.C., and Mukherjee A.B. Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1826-1834
30. Kim S.J., Zhang Z., Lee Y.C., and Mukherjee A.B. Palmitoyl-protein thioesterase-1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1580-1586
31. Zhang Z., Lee Y.C., Kim S.J., Choi M.S., Tsai P.C., Xu Y., Xiao Y.J., Zhang P., Heffer A., and Mukherjee A.B. Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL. Hum. Mol. Genet. 15 (2006) 337-346
32. R.C. Baek, D.R. Martin, N.R. Cox, T.N. Seyfried, Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff Disease, Lipids, in press, doi:10.1007/s11745.008.3268.
33. Griffin B., and Baker H.J. Domestic cats as laboratory animals. In: Fox J.G., Anderson L.C., Lowe F.M., and Quimby F.W. (Eds). Laboratory Animal Medicine (2002), Academic Press, New York, NY 460-482
34. Haskins M., Baker H.J., Birkenmeier E., Hoogerbrugge P.M., Poorthuis B.J.H.M., Sakiyama T., Shull R.M., Taylor R.M., Thrall M.A., and Walkley S.U. Transplantation in animal model systems. In: Desnick R.J. (Ed). Treatment of Genetic Diseases (1991), Churchill Livingstone, New York 183-201
35. Walkley S.U., and Dobrenis K. Bone marrow transplantation for lysosomal diseases. Lancet 345 (1995) 1382-1383
36. Vite C.H., Passini M.A., Haskins M.E., and Wolfe J.H. Adeno-associated virus vector-mediated transduction in the cat brain. Gene Ther. 10 (2003) 1874-1881
37. Jolly R.D., and Walkley S.U. Lysosomal storage diseases of animals: an essay in comparative pathology. Vet. Pathol. 34 (1997) 527-548
38. Crawley A.C., Muntz F.H., Haskins M.E., Jones B.R., and Hopwood J.J. Prevalence of mucopolysaccharidosis type VI mutations in Siamese cats. J. Vet. Int. Med. 17 (2003) 495-498
39. Crawley A.C., Yogalingam G., Muller V.J., and Hopwood J.J. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. J. Clin. Invest. 101 (1998) 109-119
40. Maegawa G.H., Tropak M., Buttner J., Stockley T., Kok F., Clarke J.T., and Mahuran D.J. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis. J. Biol. Chem. 282 (2007) 9150-9161
41. Lee J.P., Jeyakumar M., Gonzalez R., Takahashi H., Lee P.J., Baek R.C., Clark D., Rose H., Fu G., Clarke J., McKercher S., Meerloo J., Muller F.J., Park K.I., Butters T.D., Dwek R.A., Schwartz P., Tong G., Wenger D., Lipton S.A., Seyfried T.N., Platt F.M., and Snyder E.Y. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med. 13 (2007) 439-447
42. Cachon-Gonzalez M.B., Wang S.Z., Lynch A., Ziegler R., Cheng S.H., and Cox T.M. Effective gene therapy in an authentic model of Tay-Sachs related diseases. Proc. Natl. Acad. Sci. USA 103 (2006) 10373-10378
43. Broekman M.L., Baek R.C., Comer L.A., Fernandez J.L., Seyfried T.N., and Sena-Esteves M. Complete correction of enzymatic deficiency and neurochemistry in the GM1 gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery. Mol. Ther. 15 (2007) 30-37